Home Rosica News Exergen Sues Brooklands Over Thermometer Patent

Exergen Sues Brooklands Over Thermometer Patent

WATERTOWN, MA – Exergen Corporation, headquartered in Watertown, MA, has filed a lawsuit in the U.S. District Court of Massachusetts against Brooklands Inc. of Boca Raton, FL, the supplier of the VeraTemp thermometer, alleging that Brooklands has infringed United States Patent No. 7,787,938 (‘938 patent) owned by Exergen. The lawsuit alleges that Defendant has been and is contributorily infringing and/or actively inducing others, including end users, to infringe the ‘938 patent, and sells the infringing thermometers with the knowledge and intent that they will be used by end users and that such use infringes the ‘938 patent, and the intent that such thermometers are especially designed to be and are used in a manner which infringes the ‘938 patent. The VeraTemp thermometer had previously been available through American Scientific Resources Inc. Kidz-Med brand.

A recognized world leader in medical and industrial non-invasive temperature technologies, Exergen has been developing and patenting its non-invasive thermometer technology for three decades. The company’s Founder and President Francesco Pompei, Ph.D, also a Harvard research scientist, is the inventor of over 60 issued United States patents.

“I began working on heat-sensing technology back in 1980;” says Dr. Pompei, “and since then have developed non-invasive temperature sensors that are used in a multitude of applications, from home and professional medical thermometers to heat sensors used by NASA.” Dr. Pompei adds, “Filing this Complaint was predicated on the importance of protecting our technology and our company.”

Exergen’s patented award-winning TemporalScannerTM temporal artery thermometers are US-made, used in thousands of hospitals and clinics and millions of homes, with retail models being sold in Walmart, Walgreens, Target, Rite Aid, Costco, BJ’s, Babies R US and Toys R Us. Exergen is asking the Court to enjoin the defendant from further infringement of its patents and award damages resulting from the infringement.